Moderna Stock Soars On ' Transformational ' Potential Of Its Merck-Tied Cancer Vaccine

Moderna's (MRNA) Merck (MRK)-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients, the companies said Thursday. The update fueled big gains for Moderna stock, which has been hamstrung recently on Covid news. The companies followed patients who received a…#merck #keytruda #stephanebancel #rbccapitalmarkets #lucaissi #moderna #pfe #importantly #phase2 #rbc
Source: Reuters: Health - Category: Consumer Health News Source Type: news